Evidence map›Paper›PMID 12088149›Full record

ArticleRNA (New York, N.Y.)2002

Autoimmune epitopes in messenger RNA.

Barbara D Lipes, Jack D Keene

Open access · bronzeAbstract read
In one paragraph

Article in RNA (New York, N.Y.), 2002. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.6field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 16 citations in OpenAlex.

  1. Immunogenicity ofAccounts of chemical research · 2021
    Review
  2. Article
  3. Article
  4. mRNA-based therapeutics--developing a new class of drugs.Nature reviews. Drug discovery · 2014
    Review
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Barbara D LipesDepartment of Microbiology, Duke University Medical Center, Durham, North Carolina 27710, USA.
Jack D Keene
Duke University Hospital · US

Funding

FUNCTION OF MAMMALIAN ELAV RNA BINDING PROTEINSR01CA079907 · NCI · DUKE UNIVERSITY · PI KEENE, JACK D · 1999 to 2003
$1.3M
DETERMINANTS OF SPECIFICITY IN PROTEIN/RNA INTERACTIONSR01CA060083 · NCI · DUKE UNIVERSITY · PI KEENE, JACK D · 1993 to 1997
–
NCI NIH HHS CA-60083NCI NIH HHS CA-79907NCI NIH HHS T32 CA090111-22
6 · The paper itself

Abstract

Patients with systemic autoimmune disorders produce autoantibodies against sequence-specific conformational RNA epitopes on U1 snRNA, 28S rRNA, and transfer RNAs. The molecular basis for immunological reactivity with these highly abundant and stable RNAs is not understood. Here, we report the existence of discrete RNA epitopes in messenger RNAs that are generally less abundant and less stable than snRNAs and tRNAs. An iterative selection and amplification procedure using pooled autoimmune patient sera identified immunoreactive mRNA species. Following deconvolution of the pools to identify the reactive sera, several mRNAs recognized by these autoantibodies were cloned and sequenced. Detailed analysis using one particular serum indicated reactivity against the messages encoding alternative splicing factor (ASF/SF2) and calmodulin. Deletion and site-directed mutagenesis determined that an epitope recognized by this serum is located in a 17-base stem-loop structure common to both messages. This serum was then used to immunoprecipitate native mRNAs encoding ASF/SF2 and calmodulin from total HeLa cell RNA. Our results demonstrate that despite its low abundance and instability, messenger RNA is capable of reacting with autoantibodies generated during an autoimmune response. These data are consistent with direct presentation as a model to explain the generation of RNA conformation-specific autoantibodies.

Indexed as

AutoantibodiesBase SequenceCalmodulinEpitopesHumansMolecular Sequence DataMutagenesis, Site-DirectedPrecipitin TestsProtein ConformationRNA, MessengerAutoantibodiesCalmodulinEpitopesRNA, Messenger

Identifiers

PMID12088149
PMCPMC1370295
OpenAlexW2155562172

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.